Good Evening-
I was a little bored this evening so I did a compairison between DNAP and a company that is compairable in the Geno field- GNSC.
GNSC has a O/S of 22.65 million shares, with the recient share price of 22.12, so you multiply it out and it has a market cap of 501.018 million. Now take DNAP O/S of (I think this is right) 350 million shares and divide it by GNSC's marlet cap and you get 1.43 cents per share. So by those numbers we are way undervalued and a dollar a shares isnt to far fetched for the near future. DNAP gets a pharmasutical company to fund some research, and a insurance company to join in and 1.43 would be undervalued. I was reading into GNSC and they are basicicly in the same bussiness, except they are a NASDAQ stock and we are still a pink sheet stock, and hopfully we will soon be at least a BB. I think the only thing at this point that is a black flag against this stock is the O/S. The consultants they are hiring are top notch, well known in there fields and they also have a CEO who is dedicated to see this thing flurish(they are paid in shares, so that helps with the motivation). I personally think the only thing holding back some investors is the reverse split thought. A reverse is a stocks death wish, but accourding to the CEO there is no plan of one at this point which I think is not good wording by the CEO. I have personally been in a stock where the CEO said no R/S, then a few months later, after they announced a good PR, at the bottom of it, sorta like a "by the way" we are doing a 30-1 R/S, and needless to say it has droped back to its pre-R/S range and is hurting. So there is something to think about, the numbers look good, but compaired to GNSC, we are undervalued, hopfuly we have a drug company in the pipe lines, and a insurance company. Those together would rationalise a higher market cap then the competors, and hopfully give us the 4 dollar price to go NASDAQ. AMEX wouldnt be bad, sorta like a back door into the NASDAQ, and AMEX dosnt have such stringent price and market cap limits to be listed, thus there would be no need for a R/S ever!
Happy Trading,
Chris B
